Healthcare & Life Sciences
Verigraft
alive
2
Investors
About
Verigraft develops personalized tissue-engineered vein therapies using donated human tissue combined with the patient’s own blood to treat chronic venous insufficiency and improve vein function while reducing rejection risk.
Explore Verigraft's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.